EMA starts review into hair loss drugs about potential link to suicidal thoughts
The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of finasteride.
The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of finasteride.
What's Your Reaction?
